GlassScriptPhysician profile
Kazi E Syed
NPI 1598881021
$4,175.39
in general payments reported to CMS, 2019-2025
49 companies · $889 in 2025
The $889 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $597 · 2020: $267 · 2021: $126 · 2022: $582 · 2023: $958 · 2024: $757 · 2025: $889.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,592 · Education: $12.01.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,591.90 |
| Education | $12.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $846.95 | 2021-2025 | Ubrelvy, Qulipta, Botox |
| Ucb, INC. | $444.40 | 2019-2025 | Nayzilam, Briviact, Rystiggo |
| Harmony Biosciences LLC | $322.25 | 2020-2025 | Wakix |
| Jazz Pharmaceuticals INC. | $304.44 | 2019-2025 | |
| Axsome Therapeutics, INC. | $292.69 | 2023-2025 | Sunosi |
| Pfizer INC. | $210.23 | 2023-2025 | |
| Azurity Pharmaceuticals, INC. | $146.58 | 2023-2025 | Horizant, Horizant |
| Supernus Pharmaceuticals, INC. | $97.61 | 2019-2020 | |
| Allergan, INC. | $95.85 | 2019-2020 | |
| Avadel Cns Pharmaceuticals, LLC | $90.79 | 2024-2025 | Lumryz |
| Amgen INC. | $89.16 | 2019-2022 | |
| Medtronic USA, INC. | $77.72 | 2019 | |
| Biogen, INC. | $72.24 | 2022-2025 | Tysabri, Vumerity |
| Teva Pharmaceuticals USA, INC. | $67.47 | 2019-2024 | Ajovy |
| Genzyme Corporation | $65.00 | 2025 |
Show all 49 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kazi Syed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.